Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:50 pm Sale | 2024-09-30 | 13G | Aura Biosciences, Inc. AURA | Lundbeckfond Invest A/S | 1,750,108 3.500% | -267,544 (-13.26%) | Filing History |
| 2024-11-14 5:49 pm Sale | 2024-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Lundbeckfond Invest A/S | 942,671 2.900% | -893,288 (-48.66%) | Filing History |
| 2024-11-14 5:48 pm Sale | 2024-09-30 | 13G | scPharmaceuticals Inc. SCPH | Lundbeckfond Invest A/S | 2,863,987 5.700% | -319,999 (-10.05%) | Filing History |
| 2024-02-14 4:34 pm Purchase | 2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Lundbeckfond Invest A/S | 1,835,959 6.900% | 1,835,959 (New Position) | Filing History |
| 2023-08-14 3:45 pm Purchase | 2023-08-09 | 13D | IO Biotech, Inc. IOBT | Lundbeckfond Invest A/S | 21,851,920 29.600% | 15,802,468 (+261.22%) | Filing History |
| 2022-01-26 4:15 pm Unchanged | 2021-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Lundbeckfond Invest A/S | 1,151,544 4.500% | 0 (Unchanged) | Filing History |
| 2022-01-26 4:10 pm Purchase | 2021-12-31 | 13G | Reneo Pharmaceuticals, Inc. RPHM | Lundbeckfond Invest A/S | 203,122 8.300% | 203,122 (New Position) | Filing History |
| 2022-01-26 4:06 pm Purchase | 2021-12-31 | 13G | Aura Biosciences, Inc. AURA | Lundbeckfond Invest A/S | 2,017,652 6.900% | 2,017,652 (New Position) | Filing History |
| 2021-11-19 4:15 pm Purchase | 2021-11-09 | 13D | IO Biotech, Inc. IOBT | Lundbeckfond Invest A/S | 6,049,452 21.800% | 6,049,452 (New Position) | Filing History |
| 2021-02-03 4:31 pm Purchase | 2020-12-31 | 13G | IMARA Inc. IMRA | Lundbeckfond Invest A/S | 358,181 8.200% | 358,181 (New Position) | Filing History |
| 2020-01-31 4:20 pm Sale | 2019-12-31 | 13G | Spero Therapeutics, Inc. SPRO | Lundbeckfond Invest A/S | 877,489 4.600% | -214,285 (-19.63%) | Filing History |
| 2020-01-31 4:19 pm Purchase | 2019-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Lundbeckfond Invest A/S | 1,151,544 6.500% | 1,151,544 (New Position) | Filing History |